Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ε4 allele

Although apolipoprotein E ε4 is an established risk factor for Alzheimer's disease, its effect on the rate of progression of Alzheimer's disease remains unknown. The purpose of this longitudinal study was to elucidate whether the rate of hippocampal atrophy is a function of the apolipoprotein E genotypes and severity of disease. Fifty‐five patients with probable Alzheimer's disease were the subjects. The annual rate of hippocampal atrophy was determined by using magnetic resonance imaging repeated at a 1‐year interval. On a two‐way analysis of variance, the effect of the apolipoprotein E ε4 allele on hippocampal atrophy was significant, but neither the effect of severity nor the interaction term was significant. In further analysis with one‐way analysis of variance, the mean annual rate of hippocampal atrophy was significantly different between the groups of patients with (9.76 ± 4.27%) and without the apolipoprotein E ε4 allele (6.99 ± 4.24%). Apolipoprotein E ε4 dose was significantly correlated with the rate of hippocampal atrophy (rs = 0.277, Spearman rank correlation coefficient), suggesting a gene dose effect. The involvement of the apolipoprotein E ε4 allele in the progression of hippocampal atrophy has implications for therapeutic approaches in Alzheimer's disease and should be taken into consideration in longitudinal studies including clinical drug trials.

[1]  K. Davis,et al.  The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. , 1983, Psychopharmacology bulletin.

[2]  S. Corkin,et al.  Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease , 1996, Neurology.

[3]  H. Soininen,et al.  Longitudinal SPECT study in Alzheimer’s disease: relation to apolipoprotein E polymorphism , 1998, Journal of neurology, neurosurgery, and psychiatry.

[4]  A. Kurz,et al.  Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease , 1996, Neurology.

[5]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.

[6]  S. Resnick,et al.  Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype , 2000, Neurology.

[7]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[8]  E G Tangalos,et al.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.

[9]  Hiroaki Kazui,et al.  Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease , 2001, Neurology.

[10]  PhilipR. Wenham,et al.  Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.

[11]  R. Brookmeyer,et al.  Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. , 1996, Archives of neurology.

[12]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[13]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions , 1995, Journal of neural transmission. Parkinson's disease and dementia section.

[14]  Steven D. Edland,et al.  Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease , 1998, Neurology.

[15]  A. M. Saunders,et al.  Apolipoprotein E ϵ4 allele and hippocampal volume in twins with normal cognition , 1997, Neurology.

[16]  E G Tangalos,et al.  Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects , 1998, Neurology.

[17]  R. Brookmeyer,et al.  Apolipoprotein E genotype and rate of decline in probabole Alzheimer's disease , 1996 .

[18]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[19]  K. Welsh-Bohmer,et al.  Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. , 1997, Neurology.

[20]  K. Ishii,et al.  Lack of Association of Apolipoprotein E ε4 Allele Dose with Cerebral Glucose Metabolism in Alzheimer Disease , 1998 .

[21]  E. Mori,et al.  Clinical Diagnosis of Dementia with Lewy Bodies in a Japanese Dementia Registry , 1999, Dementia and Geriatric Cognitive Disorders.

[22]  E B Larson,et al.  Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. , 1998, Neurology.

[23]  Charles DeCarli,et al.  APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.

[24]  E. Mori,et al.  Amygdalar volume and emotional memory in Alzheimer's disease. , 1999, The American journal of psychiatry.

[25]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[26]  H. Soininen,et al.  SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[27]  Daniel Bandy,et al.  Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease , 1998, Annals of neurology.

[28]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[29]  C. Jack,et al.  MRI‐Based Hippocampal Volume Measurements in Epilepsy , 1994, Epilepsia.

[30]  J. Yesavage,et al.  No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. , 1997, The American journal of psychiatry.

[31]  S Kobashi,et al.  Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. , 1998, Radiology.

[32]  E. Mori,et al.  Medial temporal structures relate to memory impairment in Alzheimer’s disease: an MRI volumetric study , 1997, Journal of neurology, neurosurgery, and psychiatry.

[33]  H. Soininen,et al.  SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E £4 allele , 2022 .

[34]  H. Soininen,et al.  Apolipoprotein E, memory and Alzheimer's disease , 1996, Trends in Neurosciences.

[35]  Yutaka Hata,et al.  Automated segmentation of human brain MR images aided by fuzzy information granulation and fuzzy inference , 2000, IEEE Trans. Syst. Man Cybern. Part C.

[36]  E. Mori,et al.  Medial temporal and whole-brain atrophy in dementia with Lewy bodies , 1998, Neurology.

[37]  E. Corder,et al.  Apolipoprotein E Genotype and Rate of Decline in Probable Alzheimer's Disease , 1996 .

[38]  Minoru Yasuda,et al.  Apolipoprotein E ε4 Allele and Whole Brain Atrophy in Late-Onset Alzheimer's Disease , 1998 .